Rodino-Klapac Louise bought SRPT
June 21, 2024 · Form 4 insider transaction
Rodino-Klapac Louise bought 6,250 shares of Sarepta Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,250
Price
N/A
Total value
N/A
InsiderRodino-Klapac Louise
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 21, 2024
Filing dateJune 25, 2024
Shares owned after74,323
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares earned and vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU.